Retatrutide 10 mg Retatrutide 10 mg
Dragon Pharma

Retatrutide 10 mg

RETATRUTIDE 10 MG INJECTION
Drug Class: Triple Agonist (GLP-1 + GIP + Glucagon Receptor Agonist)
Composition:
- Active Substance: Retatrutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

72.50 USD 145.00 USD
Shipping From:
International
U.S. Domestic
You will save 72.50 USD

Retatrutide 10 mg Detailed

Lab-Tested Dragon Pharma Retatrutide 10 mg

retatrutide lab test report

What Is Retatrutide 10 mg?

Retatrutide is a novel multi-agonist peptide targeting GLP-1, GIP, and glucagon receptors to promote powerful weight loss and metabolic enhancement. Designed for subcutaneous injection, this 10 mg vial by Dragon Pharma is a cutting-edge solution for obesity management, appetite suppression, and glucose regulation.

Recent clinical trials have shown Retatrutide to reduce body weight by up to 24% in obese individuals. It outperforms semaglutide and tirzepatide in early studies. Read the Phase 2 results published in NEJM.

Key Benefits of Retatrutide

  • Promotes significant fat loss and body recomposition
  • Suppresses appetite and food cravings
  • Improves insulin sensitivity and glycemic control
  • Supports cardiovascular and liver health
  • Triple-action targeting GLP-1, GIP, and glucagon pathways

This peptide is being explored as a next-generation obesity therapy with broad metabolic and hormonal benefits—without the need for stimulants or strict dieting.

How to Use Retatrutide 10 mg

Reconstitute with 1–2 mL of bacteriostatic water. Administer via subcutaneous injection once weekly. Initial doses often start at 0.5–1 mg/week and gradually titrate to a full dose of up to 8–12 mg/week based on individual response and tolerance.

Injections should be done consistently on the same day each week. Best injected in the abdomen or thigh.

Stacking Recommendations

Retatrutide can be stacked with non-overlapping peptides for advanced body transformation or wellness goals:

  • CJC-1295 DAC – enhances GH output and muscle tone
  • BPC 157 5 mg – supports recovery and GI tract health during weight loss
  • GHK-CU 10 mg – improves skin and tissue elasticity while cutting
  • Semaglutide 5 mg – an alternative or mild adjunct for metabolic priming

This innovative GLP-1/GIP/glucagon agonist from Dragon Pharma offers a clinical-grade edge in fat loss therapy.

Side Effects and Considerations

Most common side effects include nausea, fatigue, constipation, or decreased appetite—typically during the titration period. These symptoms usually resolve after the first few weeks. Always consult a licensed provider before starting any GLP-1-based therapy.

Conclusion

Retatrutide 10 mg for Sale is a game-changing weight loss peptide engineered for powerful body fat reduction, hormonal regulation, and appetite control. This advanced Dragon Pharma formulation supports sustainable transformation in those serious about fat loss and metabolic health.

Frequently Asked Questions

What is Retatrutide used for?

Retatrutide is a triple agonist peptide used to promote weight loss, reduce appetite, and improve glucose control. It targets GLP-1, GIP, and glucagon receptors for broad metabolic effects.

How effective is Retatrutide?

In clinical studies, Retatrutide has shown body fat reduction of up to 24% in obese patients—outperforming many current GLP-1 agonists like semaglutide or tirzepatide.

How do I take Retatrutide 10 mg?

Retatrutide is injected subcutaneously once per week. Start with a low dose (0.5–1 mg/week) and gradually increase to full dosage as tolerated under medical supervision.

What are the side effects of Retatrutide?

Common side effects include nausea, constipation, low appetite, or fatigue. These effects are usually mild and subside after initial dose adjustment.

No reviews found

Please log in to write Retatrutide 10 mg review.

Related Offers
US Domestic & International
Sermorelin 5 mg
Dragon Pharma, Europe

SERMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Sermorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
US Domestic & International
PT-141 10 mg
Dragon Pharma, Europe

BREMELANOTIDE 10 MG INJECTION
Drug Class: Selective Melanocortin Receptor Agonist
Composition:
- Active Substance: Bremelanotide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
Lab Tested
US Domestic & International
BPC 157 5 mg
Dragon Pharma, Europe

PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

40.00 USD  
US Domestic & International
Tesamorelin 5 mg
Dragon Pharma, Europe

TESAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Tesamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

70.00 USD  
Lab Tested
US Domestic & International
Tirze-Pep 5 mg
Dragon Pharma, Europe

TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

90.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: